28
Views
87
CrossRef citations to date
0
Altmetric
Article

FoxO4 Regulates Tumor Necrosis Factor Alpha-Directed Smooth Muscle Cell Migration by Activating Matrix Metalloproteinase 9 Gene Transcription

, , , , &
Pages 2676-2686 | Received 15 Sep 2006, Accepted 12 Jan 2007, Published online: 27 Mar 2023

REFERENCES

  • Abid, M. R., K. Yano, S. Guo, V. I. Patel, S. Shrikhande, K. C. Spokes, C. Ferran, and W. C. Aird. 2005. Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. J. Biol. Chem. 280:29864–29873.
  • Accili, D., and K. C. Arden. 2004. Foxos at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117:421–426.
  • Ainbinder, E., M. Revach, O. Wolstein, S. Moshonov, N. Diamant, and R. Dikstein. 2002. Mechanism of rapid transcriptional induction of tumor necrosis factor alpha-responsive genes by NF-κB. Mol. Cell. Biol. 22:6354–6362.
  • Bond, M., R. P. Fabunmi, A. H. Baker, and A. C. Newby. 1998. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett. 435:29–34.
  • Brunet, A., L. B. Sweeney, J. F. Sturgill, K. F. Chua, P. L. Greer, Y. Lin, H. Tran, S. E. Ross, R. Mostoslavsky, H. Y. Cohen, L. S. Hu, H. L. Cheng, M. P. Jedrychowski, S. P. Gygi, D. A. Sinclair, F. W. Alt, and M. E. Greenberg. 2004. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011–2015.
  • Essers, M. A., S. Weijzen, A. M. de Vries-Smits, I. Saarloos, N. D. de Ruiter, J. L. Bos, and B. M. Burgering. 2004. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23:4802–4812.
  • Goossens, V., J. Grooten, K. De Vos, and W. Fiers. 1995. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. USA 92:8115–8119.
  • He, C. 1996. Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. Cancer Lett. 106:185.
  • Hosaka, T., W. H. Biggs III, D. Tieu, A. D. Boyer, N. M. Varki, W. K. Cavenee, and K. C. Arden. 2004. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. USA 101:2975–2980.
  • Johnson, C., and Z. S. Galis. 2004. Matrix metalloproteinase-2 and -9 differentially regulates smooth muscle cell migration and cell-mediated collagen organization. Arterioscler. Thromb. Vasc. Biol. 24:54–60.
  • Kumar, A., and V. Linder. 1997. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler. Thromb. Vasc. Biol. 17:2238–2244.
  • Lehtinen, M. K., Z. Yuan, P. R. Boag, Y. Yang, J. Villen, E. B. Becker, S. DiBacco, N. de la Iglesia, S. Gygi, T. K. Blackwell, and A. Bonni. 2006. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125:987–1001.
  • Liu, Z. P., Z. Wang, H. Yanagisawa, and E. N. Olson. 2005. Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. Dev. Cell 9:261–270.
  • Luttun, A., E. Lutgens, A. Manderveld, K. Maris, D. Collen, P. Carmeliet, and L. Moons. 2004. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 109:1408–1414.
  • Miano, J. M. 2002. Mammalian smooth muscle differentiation: origins, markers and transcriptional control. Results Probl. Cell Differ. 38:39–59.
  • Majesky, M. W. 2003. Vascular smooth muscle diversity: insights from developmental biology. Curr. Atheroscler. Rep. 5:208–213.
  • McCawley, L. J., and L. M. Matrisian. 2001. Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 13:534–540.
  • Moon, S. K., H. M. Kim, Y. C. Lee, and C. H. Kim. 2004. Disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression. J. Biol. Chem. 279:33063–33070.
  • Morris, B. J. 2005. A forkhead in the road to longevity: the molecular basis of lifespan becomes clearer. J. Hypertens. 23:1285–1309.
  • Newby, A. C. 2005. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85:1–31.
  • Oh, S. W., A. Mukhopadhyay, N. Svrzikapa, F. Jiang, R. J. Davis, and H. A. Tissenbaum. 2005. JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. Proc. Natl. Acad. Sci. USA 102:4494–4499.
  • Ono, H., T. Ichiki, H. Ohtsubo, K. Fukuyama, I. Imayama, Y. Hashiguchi, J. Sadoshima, and K. Sunagawa. 2005. Critical role of Mst1 in vascular remodeling after injury. Arterioscler. Thromb. Vasc. Biol. 25:1871–1876.
  • Owens, G. K., M. S. Kumar, and B. R. Wamhoff. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84:767–801.
  • Paik, J.-H., R. Kollipara, G. Chu, H. Ji, Y. Xiao, Z. Ding, L. Miao, Z. Tothova, J. W. Horner, D. R. Carrasco, S. Jiang, D. G. Gilliland, L. Chin, W. H. Wong, D. H. Castrillon, and R. A. DePinho. 2007. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128:309–323.
  • Pazdrak, K., X. Z. Shi, and S. K. Sarna. 2004. TNFalpha suppresses human colonic circular smooth muscle cell contractility by SP1- and NF-kappaB-mediated induction of ICAM-1. Gastroenterology 127:1096–1109.
  • Ray, J. L., R. Leach, J. M. Herbert, and M. Benson. 2001. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci. 23:185–188.
  • Rectenwald, J. E., L. L. Moldawer, T. S. Huber, J. M. Seeger, and C. K. Ozaki. 2000. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 102:1697–1702.
  • St-Pierre, Y., J. Couillard, and C. Themsche. 2004. Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases. Expert Opin. Ther. Targets 8:473–489.
  • Sunayama, J., F. Tsuruta, N. Masuyama, and Y. Gotoh. 2005. JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J. Cell Biol. 170:295–304.
  • Van Der Heide, L. P., M. F. Hoekman, and M. P. Smidt. 2004. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem. J. 380:297–309.
  • Vogt, P. K., H. Jiang, and M. Aoki. 2005. Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle 4:7.
  • Wang, M. C., D. Bohmann, and J. Jasper. 2005. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 121:115–125.
  • Wang, Z., M. R. Castresana, and W. H. Newman. 2001. NF-kappaB is required for TNF-alpha-directed smooth muscle cell migration. FEBS Lett. 508:360–364.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.